These findings suggest that high infiltration of MCT1+CD163+ macrophages in the tissue is not superior to high infiltration of MCT1+CD163+ macrophages in the margin for the prediction of breast cancer progression. This evidence concerns the gene SLC16A1 and breast cancer.